Company · CIK 1787400
Nkarta, Inc.
| CIK | 1787400 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | NKTX (Nasdaq) |
| First annual or quarterly report | 2020-08-20 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294611 | 2026-03-25 | 2026-04-03 | 3 | |
| 333-270680 | 2023-03-17 | 2024-03-26 | 3 | |
| 333-258766 | 2021-08-12 | 2022-04-26 | 5 | |
| 333-239301 | 2020-06-19 | 2020-07-13 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-03 | EFFECTDeclared effective | 333-294611 | 9999999995-26-001085 |
| 2026-04-03 | 424B5Shelf takedown | 333-294611 | 0001140361-26-013179 |
| 2026-03-25 | S-3Shelf registered | 333-294611 | 0001140361-26-011152 |
| 2024-03-26 | 424B5Shelf takedown | 333-270680 | 0001140361-24-015094 |
| 2023-05-05 | EFFECTDeclared effective | 333-270680 | 9999999995-23-001318 |
| 2023-03-17 | S-3Shelf registered | 333-270680 | 0001193125-23-074079 |
| 2022-04-26 | 424B5Shelf takedown | 333-258766 | 0001193125-22-120195 |
| 2022-04-25 | 424B5Shelf takedown | 333-258766 | 0001193125-22-117512 |
| 2021-09-03 | 424B5Shelf takedown | 333-258766 | 0001193125-21-264680 |
| 2021-09-02 | EFFECTDeclared effective | 333-258766 | 9999999995-21-003394 |
| 2021-08-12 | S-3Shelf registered | 333-258766 | 0001193125-21-244848 |
| 2020-07-13 | 424B4Final prospectus | 333-239301 | 0001193125-20-191255 |
| 2020-07-09 | EFFECTDeclared effective | 333-239301 | 9999999995-20-001739 |
| 2020-07-09 | S-1/AAmendment | 333-239301 | 0001193125-20-190401 |
| 2020-07-09 | S-1/AAmendment | 333-239301 | 0001193125-20-189883 |
| 2020-07-02 | S-1/AAmendment | 333-239301 | 0001193125-20-186953 |
| 2020-06-19 | S-1Registration filed | 333-239301 | 0001193125-20-173939 |
| 2020-02-28 | DRSDraft made public | 377-03070 | 0000950123-20-002705 |